KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Assets Average (2018 - 2025)

Amneal Pharmaceuticals has reported Assets Average over the past 8 years, most recently at $3.6 billion for Q4 2025.

  • Quarterly results put Assets Average at $3.6 billion for Q4 2025, up 4.53% from a year ago — trailing twelve months through Dec 2025 was $3.6 billion (up 4.53% YoY), and the annual figure for FY2025 was $3.6 billion, up 2.95%.
  • Assets Average for Q4 2025 was $3.6 billion at Amneal Pharmaceuticals, up from $3.5 billion in the prior quarter.
  • Over the last five years, Assets Average for AMRX hit a ceiling of $4.0 billion in Q3 2021 and a floor of $3.4 billion in Q2 2025.
  • Median Assets Average over the past 5 years was $3.7 billion (2023), compared with a mean of $3.7 billion.
  • Biggest five-year swings in Assets Average: dropped 7.6% in 2023 and later grew 4.53% in 2025.
  • Amneal Pharmaceuticals' Assets Average stood at $4.0 billion in 2021, then fell by 3.04% to $3.8 billion in 2022, then dropped by 6.69% to $3.6 billion in 2023, then dropped by 2.75% to $3.5 billion in 2024, then grew by 4.53% to $3.6 billion in 2025.
  • The last three reported values for Assets Average were $3.6 billion (Q4 2025), $3.5 billion (Q3 2025), and $3.4 billion (Q2 2025) per Business Quant data.